VGF ablation blocks the development of hyperinsulinemia and hyperglycemia in several mouse models of obesity.

Targeted deletion of the gene encoding the neuronal and endocrine secreted peptide precursor called VGF (nonacronymic) produces a lean, hypermetabolic, hyperactive mouse. Because VGF mutant mice are resistant to specific forms of diet-, lesion-, and genetically induced obesity, we investigated the role that this polypeptide plays in glucose homeostasis. We report that VGF mutant mice have increased insulin sensitivity by hyperinsulinemic euglycemic clamp analysis, and by insulin and glucose tolerance testing. Blunted counterregulatory responses in VGF-deficient mice were likely influenced by their significantly lower liver glycogen levels. VGF deficiency lowered circulating glucose and insulin levels in several murine models of obesity that are also susceptible to adult onset diabetes mellitus, including A(y)/a agouti, ob/ob, and MC4R(-)/MC4R(-) mice. Interestingly, ablation of Vgf in ob/ob mice decreased circulating glucose and insulin levels but did not affect adiposity, whereas MC4R(-)/MC4R(-) mice that are additionally deficient in VGF have improved insulin responsiveness at 7-8 wk of age, when lean MC4R(-)/MC4R(-) mice already have impaired insulin tolerance but are not yet obese. VGF mutant mice also resisted developing obesity and hyperglycemia in response to a high-fat/high-carbohydrate diet, and after gold thioglucose treatment, which is toxic to hypothalamic glucose-sensitive neurons. Lastly, circulating adiponectin, an adipose-synthesized protein the levels of which are correlated with improved insulin sensitivity, increased in VGF mutant compared with wild-type mice. Modulation of VGF levels and/or VGF signaling may consequently represent an alternative means to regulate circulating glucose levels and insulin sensitivity.

[1]  T. Kowalski,et al.  Transgenic overexpression of neuromedin U promotes leanness and hypophagia in mice. , 2005, The Journal of endocrinology.

[2]  B. Lowell,et al.  Mitochondrial Dysfunction and Type 2 Diabetes , 2005, Science.

[3]  M. Lipsett,et al.  Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice. , 2004, American journal of physiology. Endocrinology and metabolism.

[4]  M. Reitman,et al.  Increased insulin sensitivity in paternal Gnas knockout mice is associated with increased lipid clearance. , 2004, Endocrinology.

[5]  R. Possenti,et al.  Processing, Distribution, and Function of VGF, a Neuronal and Endocrine Peptide Precursor , 2004, Cellular and Molecular Neurobiology.

[6]  H. Lodish,et al.  A family of Acrp30/adiponectin structural and functional paralogs. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Jamie T. Lewis,et al.  Leptin increases hepatic insulin sensitivity and protein tyrosine phosphatase 1B expression. , 2004, Molecular endocrinology.

[8]  K. Yamagata,et al.  Overexpression of Pituitary Adenylate Cyclase-Activating Polypeptide in Islets Inhibits Hyperinsulinemia and Islet Hyperplasia in Agouti Yellow Mice , 2004, Journal of Pharmacology and Experimental Therapeutics.

[9]  H. Lodish,et al.  Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle. , 2004, The Journal of clinical investigation.

[10]  C. Mobbs,et al.  Transgenic neuronal expression of proopiomelanocortin attenuates hyperphagic response to fasting and reverses metabolic impairments in leptin-deficient obese mice. , 2003, Diabetes.

[11]  J. Clapham,et al.  Increased fatty acid oxidation in transgenic mice overexpressing UCP3 in skeletal muscle , 2003, Diabetes, obesity & metabolism.

[12]  B. Goodpaster,et al.  Enhanced fat oxidation through physical activity is associated with improvements in insulin sensitivity in obesity. , 2003, Diabetes.

[13]  C. Mantzoros,et al.  Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance. , 2003, Obesity research.

[14]  C. Mobbs,et al.  Central pro-opiomelanocortin gene delivery results in hypophagia, reduced visceral adiposity, and improved insulin sensitivity in genetically obese Zucker rats. , 2003, Diabetes.

[15]  J. Flier,et al.  Melanin-concentrating hormone is a critical mediator of the leptin-deficient phenotype , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[16]  W. Saris,et al.  Effect of beta1- and beta2-adrenergic stimulation on energy expenditure, substrate oxidation, and UCP3 expression in humans. , 2003, American journal of physiology. Endocrinology and metabolism.

[17]  P. Iyengar,et al.  Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. , 2003, Diabetes.

[18]  J. Holst,et al.  Effects of free fatty acids per se on glucose production, gluconeogenesis, and glycogenolysis. , 2003, Diabetes.

[19]  H. Lodish,et al.  Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: Acetyl–CoA carboxylase inhibition and AMP-activated protein kinase activation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Zolotukhin,et al.  Regulation of adiponectin and leptin gene expression in white and brown adipose tissues: influence of beta3-adrenergic agonists, retinoic acid, leptin and fasting. , 2002, Biochimica et biophysica acta.

[21]  M. Prentki,et al.  Coordinate Regulation of Malonyl-CoA Decarboxylase,sn-Glycerol-3-phosphate Acyltransferase, and Acetyl-CoA Carboxylase by AMP-activated Protein Kinase in Rat Tissues in Response to Exercise* , 2002, The Journal of Biological Chemistry.

[22]  C. Boozer,et al.  VGF is Required for Obesity Induced by Diet, Gold Thioglucose Treatment, and Agouti and is Differentially Regulated in Pro-Opiomelanocortin- and Neuropeptide Y-Containing Arcuate Neurons in Response to Fasting , 2002, The Journal of Neuroscience.

[23]  Zhaohui Feng,et al.  Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats , 2002, Nature Neuroscience.

[24]  H. Lodish,et al.  ACRP30, a new hormone controlling fat and glucose metabolism. , 2002, European journal of pharmacology.

[25]  M. Stumvoll,et al.  Clinical characterization of insulin secretion as the basis for genetic analyses. , 2002, Diabetes.

[26]  R. Kulkarni,et al.  A model to explore the interaction between muscle insulin resistance and beta-cell dysfunction in the development of type 2 diabetes. , 2000, Diabetes.

[27]  C. Mantzoros,et al.  Differential expression of hypothalamic neuropeptides in the early phase of diet-induced obesity in mice. , 2000, American journal of physiology. Endocrinology and metabolism.

[28]  R. Cone,et al.  The central melanocortin system can directly regulate serum insulin levels. , 2000, Endocrinology.

[29]  Robert Ross,et al.  Reduction in Obesity and Related Comorbid Conditions after Diet-Induced Weight Loss or Exercise-Induced Weight Loss in Men , 2000, Annals of Internal Medicine.

[30]  R. Possenti,et al.  VGF: A Novel Role for This Neuronal and Neuroendocrine Polypeptide in the Regulation of Energy Balance , 2000, Frontiers in Neuroendocrinology.

[31]  T. Mizuno,et al.  Of Mice and MEN What Transgenic Models Tell Us about Hypothalamic Control of Energy Balance , 2000, Neuron.

[32]  G. Shulman,et al.  On Diabetes: Insulin Resistance Cellular Mechanisms of Insulin Resistance , 2022 .

[33]  C. Mobbs,et al.  Resistance to diet-induced obesity is associated with increased proopiomelanocortin mRNA and decreased neuropeptide Y mRNA in the hypothalamus , 1999, Brain Research.

[34]  J. Franch,et al.  Regulation of glycogen synthesis in rat skeletal muscle after glycogen-depleting contractile activity: effects of adrenaline on glycogen synthesis and activation of glycogen synthase and glycogen phosphorylase. , 1999, The Biochemical journal.

[35]  C. Mobbs,et al.  Fasting Regulates Hypothalamic Neuropeptide Y, Agouti-Related Peptide, and Proopiomelanocortin in Diabetic Mice Independent of Changes in Leptin or Insulin1. , 1999, Endocrinology.

[36]  L. Yaswen,et al.  Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin , 1999, Nature Medicine.

[37]  J. Takahashi,et al.  Targeted Deletion of the Vgf Gene Indicates that the Encoded Secretory Peptide Precursor Plays a Novel Role in the Regulation of Energy Balance , 1999, Neuron.

[38]  C. Mobbs,et al.  Hypothalamic agouti-related protein messenger ribonucleic acid is inhibited by leptin and stimulated by fasting. , 1999, Endocrinology.

[39]  W. Saris,et al.  Inhibition of lipolysis reduces beta1-adrenoceptor-mediated thermogenesis in man. , 1998, Metabolism: clinical and experimental.

[40]  C. Mobbs,et al.  Hyperphagia and weight gain after gold-thioglucose: relation to hypothalamic neuropeptide Y and proopiomelanocortin. , 1998, Endocrinology.

[41]  J. Halaas,et al.  Leptin and the regulation of body weight in mammals , 1998, Nature.

[42]  J. Proietto,et al.  Reduced BAT function as a mechanism for obesity in the hypophagic, neuropeptide Y deficient monosodium glutamate-treated rat , 1998, Regulatory Peptides.

[43]  K. Ohba,et al.  The effect of acute cold exposure and norepinephrine on uncoupling protein gene expression in brown adipose tissue of monosodium glutamate-obese mice. , 1998, Japanese journal of pharmacology.

[44]  C. Priest,et al.  Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting and [corrected] in ob/ob and db/db mice, but is stimulated by leptin. , 1998, Diabetes.

[45]  C. Priest,et al.  Hypothalamic Pro-Opiomelanocortin mRNA Is Reduced By Fasting in ob/ob and db/db Mice, but Is Stimulated by Leptin , 1998, Diabetes.

[46]  G. Barsh,et al.  Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. , 1997, Science.

[47]  L. Orci,et al.  Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[48]  J. Shutter,et al.  Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. , 1997, Genes & development.

[49]  R. Cone,et al.  Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in Mice , 1997, Cell.

[50]  G. Boden.  Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM , 1997, Diabetes.

[51]  W. Bauman,et al.  Effects of nutritional status and aging on leptin gene expression in mice: importance of glucose. , 1996, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[52]  C. Mobbs,et al.  Obese gene expression: reduction by fasting and stimulation by insulin and glucose in lean mice, and persistent elevation in acquired (diet-induced) and genetic (yellow agouti) obesity. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[53]  C. Rogler,et al.  Hepatic Overexpression of Insulin-like Growth Factor-II in Adulthood Increases Basal and Insulin-stimulated Glucose Disposal in Conscious Mice (*) , 1996, The Journal of Biological Chemistry.

[54]  A. Saltiel,et al.  Activation of Mitogen-activated Protein Kinase and Phosphatidylinositol 3′-Kinase Is Not Sufficient for the Hormonal Stimulation of Glucose Uptake, Lipogenesis, or Glycogen Synthesis in 3T3-L1 Adipocytes (*) , 1995, The Journal of Biological Chemistry.

[55]  W. Pizzi,et al.  Effects of monosodium glutamate on somatic development, obesity and activity in the mouse , 1976, Pharmacology Biochemistry and Behavior.

[56]  E. Newsholme,et al.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.

[57]  G. Fraley,et al.  Immunolesion of norepinephrine and epinephrine afferents to medial hypothalamus alters basal and 2-deoxy-D-glucose-induced neuropeptide Y and agouti gene-related protein messenger ribonucleic acid expression in the arcuate nucleus. , 2003, Endocrinology.

[58]  E. Kraegen,et al.  2-deoxy-D-glucose metabolism in individual tissues of the rat in vivo. , 1986, The International journal of biochemistry.